The additional challenges to launching new drugs that emerged since COVID-19 upended the biopharma industry, and life as we knew it, will continue into 2021. Yet the challenging environment for drug development has not stopped companies from launching dozens of new treatments. GEN presents the 15 top-selling prescription drugs launched in 2020, based on sales data disclosed by the drugs’ developers through the first three quarters.